Sjögren's syndrome: Another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA)

Journal of Autoimmunity

Volumn 51, Issue , 2014, Pages 10-16

  Colafrancesco, S ^a,b   Perricone, C ^a,b   Priori, R ^a   Valesini, G ^a   Shoenfeld, Y ^b,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

ASIA; Autoantibodies; Autoimmune inflammatory syndrome induced by adjuvants; Autoimmunity; Sj gren's syndrome; Vaccine

Indexed keywords

ADJUVANT; SILICONE; VACCINE; IMMUNOLOGICAL ADJUVANT;

AUTOIMMUNE DISEASE; AUTOIMMUNE INFLAMMATORY SYNDROME INDUCED BY ADJUVANT; B LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; INFLAMMATORY DISEASE; MARGINAL ZONE LYMPHOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEX; SJOEGREN SYNDROME; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; VACCINATION; ANIMAL; AUTOIMMUNE DISEASES; AUTOIMMUNITY; INFLAMMATION; SJOGREN'S SYNDROME; SYNDROME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; INFLAMMATION; SJOGREN'S SYNDROME; SYNDROME;

EID: 84901251698     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.03.003     Document Type: Review

References (107)

1. Shoenfeld Y. Autoimmune (autoinflammatory) syndrome induced by adjuvants provides a diagnostic framework for enigmatic conditions. Rheumatologist 2011, 26-32.
2. Shoenfeld Y., Agmon-Levin N. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. JAutoimmun 2011, 36:4-8.
3. Shoenfeld Y., N A.-L. Abstract of: 'ASIA' - autoimmune (auto-inflammatory) syndrome induced by adjuvant- a new syndrome to be defined. In: Abstracts of selected invited lectures. Lupus 2011, 340-347.
4. Israeli E., Agmon-Levin N., Blank M., Shoenfeld Y. Adjuvants and autoimmunity. Lupus 2009, 18:1217-1225.
5. Agmon-Levin N., Paz Z., Israeli E., Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol 2009, 5:648-652.
6. Conti F., Rezai S., Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev 2008, 8:124-128.
7. Shoenfeld Y. Infections, vaccines and autoimmunity. Lupus 2009, 18:1127-1128.
8. Bogdanos D.P., Smyk D.S., Invernizzi P., Rigopoulou E.I., Blank M., Pouria S., et al. Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmun Rev 2013, 12:726-740.
9. Peri Y., Agmon-Levin N., Theodor E., Shoenfeld Y. Sjögren's syndrome, the old and the new. Best Pract Res Clin Rheumatol 2012, 26:105-117.
10. Igoe A., Scofield R.H. Autoimmunity and infection in Sjögren's syndrome. Curr Opin Rheumatol 2013, 25:480-487.
11. Astudillo L., Sailler L., Ecoiffier M., Giron J., Couret B., Arlet-Suau E. Exposure to silica and primary Sjögren's syndrome in a dental technician. Rheumatology (Oxford) 2003, 42:1268-1269.
12. Levy Y., Rotman-Pikielny P., Ehrenfeld M., Shoenfeld Y. Silicone breast implantation-induced scleroderma: description of four patients and a critical review of the literature. Lupus 2009, 18:1226-1232.
13. Israeli E. Gulf War syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA). Lupus 2012, 21:190-194.
14. Authier F.J., Sauvat S., Champey J., Drogou I., Coquet M., Gherardi R.K. Chronic fatigue syndrome in patients with macrophagic myofasciitis. Arthritis Rheum 2003, 48:569-570.
15. Israeli E., Pardo A. The sick building syndrome as a part of the autoimmune (auto-inflammatory) syndrome induced by adjuvants. Mod Rheumatol 2011, 21:235-239.
16. Meroni P.L. Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): old truths and a new syndrome?. JAutoimmun 2011, 36:1-3.
17. Rosenblum H., Shoenfeld Y., Amital H. The common immunogenic etiology of chronic fatigue syndrome: from infections to vaccines via adjuvants to the ASIA syndrome. Infect Dis Clin North Am 2011, 25:851-863.
18. Colafrancesco S., Agmon-Levin N., Perricone C., Shoenfeld Y. Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle. Immunol Res 2013, 56:200-205.
19. Perricone C., Ceccarelli F., Valesini G. An overview on the genetic of rheumatoid arthritis: a never-ending story. Autoimmun Rev 2011, 10:599-608.
20. Selmi C., Battezzati P.M., Gershwin M.E., Tishler M., Shoenfeld Y. Vaccines in the 21st century: the genetic response and the innocent bystander. Autoimmun Rev 2005, 4:79-81.
21. Vera-Lastra O., Medina G., Cruz-Dominguez M.e.P., Ramirez P., Gayosso-Rivera J.A., Anduaga-Dominguez H., et al. Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld's syndrome). Lupus 2012, 21:128-135.
22. Barzilai O., Ram M., Shoenfeld Y. Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol 2007, 19:636-643.
23. Murali-Krishna K., Altman J.D., Suresh M., Sourdive D.J., Zajac A.J., Miller J.D., et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998, 8:177-187.
24. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992, 358:155-157.
25. Borchers A.T., Keen C.L., Shoenfeld Y., Silva J., Gershwin M.E. Vaccines, viruses, and voodoo. JInvestig Allergol Clin Immunol 2002, 12:155-168.
26. Molina V., Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 2005, 38:235-245.
27. Basra G., Jajoria P., Gonzalez E. Rheumatoid arthritis and Swine influenza vaccine: a case report. Case Rep Rheumatol 2012, 2012:785028.
28. Zafrir Y., Agmon-Levin N., Shoenfeld Y. Post-influenza vaccination vasculitides: a possible new entity. JClin Rheumatol 2009, 15:269-270.
29. Agmon-Levin N., Kivity S., Szyper-Kravitz M., Shoenfeld Y. Transverse myelitis and vaccines: a multi-analysis. Lupus 2009, 18:1198-1204.
30. Israeli E., Agmon-Levin N., Blank M., Chapman J., Shoenfeld Y. Guillain-Barré syndrome-a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol 2012, 42:121-130.
31. Colafrancesco S., Perricone C., Tomljenovic L., Shoenfeld Y. Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants. Am J Reprod Immunol 2013, 70:309-316.
32. Amador-Patarroyo M.J., Arbelaez J.G., Mantilla R.D., Rodriguez-Rodriguez A., Cardenas-Roldan J., Pineda-Tamayo R., et al. Sjogren's syndrome at the crossroad of polyautoimmunity. JAutoimmun 2012, 39:199-205.
33. Bournia V.K., Vlachoyiannopoulos P.G. Subgroups of Sjogren syndrome patients according to serological profiles. JAutoimmun 2012, 39:15-26.
34. Cornec D., Devauchelle-Pensec V., Tobon G.J., Pers J.O., Jousse-Joulin S., Saraux A. Bcells in Sjogren's syndrome: from pathophysiology to diagnosis and treatment. JAutoimmun 2012, 39:161-167.
35. Skopouli F.N., Moutsopoulos H.M. Autoimmune epitheliitis: Sjögren's syndrome. Clin Exp Rheumatol 1994, 12(Suppl.11):S9-S11.
36. Moutsopoulos H.M. Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994, 72:162-165.
37. Ice J.A., Li H., Adrianto I., Lin P.C., Kelly J.A., Montgomery C.G., et al. Genetics of Sjogren's syndrome in the genome-wide association era. JAutoimmun 2012, 39:57-63.
38. Bogdanos D.P., Smyk D.S., Rigopoulou E.I., Mytilinaiou M.G., Heneghan M.A., Selmi C., et al. Twin studies in autoimmune disease: genetics, gender and environment. JAutoimmun 2012, 38:J156-J169.
39. Cruz-Tapias P., Rojas-Villarraga A., Maier-Moore S., Anaya J.M. HLA and Sjögren's syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev 2012, 11:281-287.
40. Priori R., Medda E., Conti F., Cassarà E.A., Sabbadini M.G., Antonioli C.M., et al. Risk factors for Sjögren's syndrome: a case-control study. Clin Exp Rheumatol 2007, 25:378-384.
41. Mavragani C.P., Fragoulis G.E., Moutsopoulos H.M. Endocrine alterations in primary Sjogren's syndrome: an overview. JAutoimmun 2012, 39:354-358.
42. Baldini C., Pepe P., Quartuccio L., Priori R., Bartoloni E., Alunno A., et al. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford) 2013, 10.1093/rheumatology/ket427.
43. Priori R., Iannuccelli C., Alessandri C., Modesti M., Antonazzo B., Di Lollo A.C., et al. Fatigue in Sjogren's syndrome: relationship with fibromyalgia, clinical and biologic features. Clin Exp Rheumatol 2010, 28:S82-S86.
44. Baldini C., Talarico R., Tzioufas A.G., Bombardieri S. Classification criteria for Sjogren's syndrome: a critical review. JAutoimmun 2012, 39:9-14.
45. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
46. Tzioufas A.G., Vlachoyiannopoulos P.G. Sjogren's syndrome: an update on clinical, basic and diagnostic therapeutic aspects. JAutoimmun 2012, 39:1-3.
47. Vitali C., Bombardieri S., Moutsopoulos H.M., Balestrieri G., Bencivelli W., Bernstein R.M., et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993, 36:340-347.
48. Abdulahad W.H., Kroese F.G., Vissink A., Bootsma H. Immune regulation and B-cell depletion therapy in patients with primary Sjogren's syndrome. JAutoimmun 2012, 39:103-111.
49. Guerrier T., Le Pottier L., Devauchelle V., Pers J.O., Jamin C., Youinou P. Role of Toll-like receptors in primary Sjogren's syndrome with a special emphasis on B-cell maturation within exocrine tissues. JAutoimmun 2012, 39:69-76.
50. Seror R., Bootsma H., Bowman S.J., Dorner T., Gottenberg J.E., Mariette X., et al. Outcome measures for primary Sjogren's syndrome. JAutoimmun 2012, 39:97-102.
51. Fox R., Fox C. Sjogren's syndrome: infections that may play a role in pathogenesis, mimic the disease, or complicate the patient's course. Indian J Rheumatol 2011, 13-25.
52. Sipsas N.V., Gamaletsou M.N., Moutsopoulos H.M. Is Sjögren's syndrome a retroviral disease?. Arthritis Res Ther 2011, 13:212.
53. Barrera M.J., Sanchez M., Aguilera S., Alliende C., Bahamondes V., Molina C., et al. Aberrant localization of fusion receptors involved in regulated exocytosis in salivary glands of Sjogren's syndrome patients is linked to ectopic mucin secretion. JAutoimmun 2012, 39:83-92.
54. Saad C.G., Borba E.F., Aikawa N.E., Silva C.A., Pereira R.M., Calich A.L., et al. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Ann Rheum Dis 2011, 70:1068-1073.
55. Milanovic M., Stojanovich L., Djokovic A., Kontic M., Gvozdenovic E. Influenza vaccination in autoimmune rheumatic disease patients. Tohoku J Exp Med 2013, 229:29-34.
56. Pasoto S.G., Ribeiro A.C., Viana V.S., Leon E.P., Bueno C., Neto M.L., et al. Short and long-term effects of pandemic unadjuvanted influenza A(H1N1)pdm09 vaccine on clinical manifestations and autoantibody profile in primary Sjögren's syndrome. Vaccine 2013, 31:1793-1798.
57. Abu-Shakra M., Press J., Sukenik S., Buskila D. Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies. Clin Rheumatol 2002, 21:369-372.
58. van Assen S., Agmon-Levin N., Elkayam O., Cervera R., Doran M.F., Dougados M., et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011, 70:414-422.
59. van Assen S., Elkayam O., Agmon-Levin N., Cervera R., Doran M.F., Dougados M., et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev 2011, 10:341-352.
60. Konttinen Y.T., Fuellen G., Bing Y., Porola P., Stegaev V., Trokovic N., et al. Sex steroids in Sjogren's syndrome. JAutoimmun 2012, 39:49-56.
61. Manoussakis M.N., Tsinti M., Kapsogeorgou E.K., Moutsopoulos H.M. The salivary gland epithelial cells of patients with primary Sjogren's syndrome manifest significantly reduced responsiveness to 17beta-estradiol. JAutoimmun 2012, 39:64-68.
62. Pennell L.M., Galligan C.L., Fish E.N. Sex affects immunity. JAutoimmun 2012, 38:J282-J291.
63. Tzioufas A.G., Kapsogeorgou E.K., Moutsopoulos H.M. Pathogenesis of Sjögren's syndrome: what we know and what we should learn. JAutoimmun 2012, 39:4-8.
64. Toussirot E., Lohse A., Wendling D., Mougin C. Sjögren's syndrome occurring after hepatitis B vaccination. Arthritis Rheum 2000, 43:2139-2140.
65. Narváez J., Castro-Bohorquez F.J., Vilaseca-Momplet J. Sjögren's-like syndrome following intravesical bacillus Calmette-Guérin immunotherapy. Am J Med 2003, 115:418-420.
66. Toussirot E., Bossert M., Herbein G., Saas P. Comments on the article by Tabache F. etal. "Acute polyarthritis after influenza A H1N1 immunization", Joint Bone Spine, 2011, doi:10.1016/j.jbs.2011.02.007: primary Sjögren's syndrome occurring after influenza A H1N1 vaccine administration. Joint Bone Spine 2012, 79:107.
67. Sanchez-Roman J., Wichmann I., Salaberri J., Varela J.M., Nuñez-Roldan A. Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 1993, 52:534-538.
68. Puisieux F., Hachulla E., Brouillard M., Hatron P.Y., Devulder B. Silicosis and primary Gougerot-Sjögren syndrome. Rev Med Interne 1994, 15:575-579.
69. Orriols R., Ferrer J., Tura J.M., Xaus C., Coloma R. Sicca syndrome and silicoproteinosis in a dental technician. Eur Respir J 1997, 10:731-734.
70. Santoro D., Vita G., Vita R., Mallamace A., Savica V., Bellinghieri G., et al. HLA haplotype in a patient with systemic lupus erythematosus triggered by hepatitis B vaccine. Clin Nephrol 2010, 74:150-153.
71. Perricone C., Shoenfeld Y. Hepatitis B vaccination and undifferentiated connective tissue disease: another brick in the wall of the autoimmune/inflammatory syndrome induced by adjuvants (Asia). JClin Rheumatol 2013, 19:231-233.
72. Zafrir Y., Agmon-Levin N., Paz Z., Shilton T., Shoenfeld Y. Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases. Lupus 2012, 21:146-152.
73. Low H.Z., Witte T. Aspects of innate immunity in Sjögren's syndrome. Arthritis Res Ther 2011, 13:218.
74. Brito-Zeron P., Retamozo S., Gandia M., Akasbi M., Perez-De-Lis M., Diaz-Lagares C., et al. Monoclonal gammopathy related to Sjogren syndrome: a key marker of disease prognosis and outcomes. JAutoimmun 2012, 39:43-48.
75. Singh N., Cohen P.L. The T cell in Sjogren's syndrome: force majeure, not spectateur. JAutoimmun 2012, 39:229-233.
76. Selmi C., Meroni P.L., Gershwin M.E. Primary biliary cirrhosis and Sjogren's syndrome: autoimmune epithelitis. JAutoimmun 2012, 39:34-42.
77. Kong L., Ogawa N., Nakabayashi T., Liu G.T., D'Souza E., McGuff H.S., et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 1997, 40:87-97.
78. Konttinen Y.T., Halinen S., Hanemaaijer R., Sorsa T., Hietanen J., Ceponis A., et al. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome. Matrix Biol 1998, 17:335-347.
79. Jonsson R., Vogelsang P., Volchenkov R., Espinosa A., Wahren-Herlenius M., Appel S. The complexity of Sjögren's syndrome: novel aspects on pathogenesis. Immunol Lett 2011, 141:1-9.
80. Gaston J.S., Rowe M., Bacon P. Sjögren's syndrome after infection by Epstein-Barr virus. JRheumatol 1990, 17:558-561.
81. de Wilde P.C., Kater L., Bodeutsch C., van den Hoogen F.H., van de Putte L.B., et al. Aberrant expression pattern of the SS-B/La antigen in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 1996, 39:783-791.
82. Tengner P., Halse A.K., Haga H.J., Jonsson R., Wahren-Herlenius M. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjogren's syndrome. Arthritis Rheum 1998, 41:2238-2248.
83. Huang Y.F., Cheng Q., Jiang C.M., An S., Xiao L., Gou Y.C., et al. The immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndrome. Clin Dev Immunol 2013, 2013:160491.
84. Varin M.M., Guerrier T., Devauchelle-Pensec V., Jamin C., Youinou P., Pers J.O. In Sjögren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmun Rev 2012, 11:252-258.
85. Daridon C., Devauchelle V., Hutin P., Le Berre R., Martins-Carvalho C., Bendaoud B., et al. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 2007, 56:1134-1144.
86. Mavragani C.P., Moutsopoulos H.M. Sjögren's syndrome. Annu Rev Pathol 2014, 9:273-285.
87. Voulgarelis M., Tzioufas A.G. Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol 2010, 6:529-537.
88. Youinou P., Pers J.O. Disturbance of cytokine networks in Sjögren's syndrome. Arthritis Res Ther 2011, 13:227.
89. Voulgarelis M., Ziakas P.D., Papageorgiou A., Baimpa E., Tzioufas A.G., Moutsopoulos H.M. Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome. Medicine (Baltimore) 2012, 91:1-9.
90. Nichter L.S., Mueller M.A., Burns R.G., Stallman J.M. First report of nodal marginal zone B-cell lymphoma associated with breast implants. Plast Reconstr Surg 2012, 129:576e-578e.
91. Kellogg B.C., Hiro M.E., Payne W.G. Implant-associated anaplastic large cell lymphoma: beyond breast prostheses. Ann Plast Surg 2013, 10.1097/SAP.0b013e31827faff2.
92. Högfeldt T., Bahnassy A.A., Kwiecinska A., Osterborg A., Tamm K.P., Porwit A., et al. Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures. Leuk Lymphoma 2013, 54:996-1003.
93. Valesini G., Conti F., Priori R. Chronic fatigue syndrome: what factors trigger it off?. Clin Exp Rheumatol 1994, 12:473-476.
94. Priori R., Conti F., Luan F.L., Arpino C., Valesini G. Chronic fatigue: a peculiar evolution of eosinophilia myalgia syndrome following treatment with L-tryptophan in four Italian adolescents. Eur J Pediatr 1994, 153:344-346.
95. Tishler M., Paran D., Yaron M. Allergic disorders in primary Sjögren's syndrome. Scand J Rheumatol 1998, 27:166-169.
96. Wang H., Wang H.S., Liu Z.P. Agents that induce pseudo-allergic reaction. Drug Discov Ther 2011, 5:211-219.
97. Gudbjörnsson B., Broman J.E., Hetta J., Hällgren R. Sleep disturbances in patients with primary Sjögren's syndrome. Br J Rheumatol 1993, 32:1072-1076.
98. Perricone C., Agmon-Levin N., Ceccarelli F., Valesini G., Anaya J.M., Shoenfeld Y. Genetics and autoantibodies. Immunol Res 2013, 56:206-219.
99. Agmon-Levin N., Kivity S., Tzioufas A.G., Lopez Hoyos M., Rozman B., Efes I., et al. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogren's syndrome. JAutoimmun 2012, 39:234-239.
100. Pavlakis P.P., Alexopoulos H., Kosmidis M.L., Mamali I., Moutsopoulos H.M., Tzioufas A.G., et al. Peripheral neuropathies in Sjogren's syndrome: a critical update on clinical features and pathogenetic mechanisms. JAutoimmun 2012, 39:27-33.
101. Takahashi H., Yamamoto M., Tabeya T., Suzuki C., Naishiro Y., Shinomura Y., et al. The immunobiology and clinical characteristics of IgG4 related diseases. JAutoimmun 2012, 39:93-96.
102. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. NEngl J Med 2003, 349:1526-1533.
103. Harima H.A., Mendes N.F., Mamizuka E.M., Mariano M. Effect of glucan on murine lupus evolution and on host resistance to Klebsiella pneumoniae. JClin Lab Anal 1997, 11:175-178.
104. Rinaldi M., Perricone R., Blank M., Perricone C., Shoenfeld Y. Anti-Saccharomyces cerevisiae autoantibodies in autoimmune diseases: from bread baking to autoimmunity. Clin Rev Allergy Immunol 2013, 45:152-161.
105. Israeli E., Grotto I., Gilburd B., Balicer R.D., Goldin E., Wiik A., et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005, 54:1232-1236.
106. Perricone C., Agmon-Levin N., Valesini G., Shoenfeld Y. Vaccination in patients with chronic or autoimmune rheumatic diseases: the ego, the id and the superego. Jt Bone Spine 2012, 79:1-3.
107. Shiboski S.C., Shiboski C.H., Criswell L., Baer A., Challacombe S., Lanfranchi H., et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012, 64:475-487. S. s. I. C. C. A. R. Groups.